Manchester Capital Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Manchester Capital Management’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$90.8K	Hold	2,160	–	–	0.01%	405
2026 Q1	$57.1K	Buy	+2,160	New	+$63.3K	0.01%	463
2025 Q2	–	Sell	-1,791	Closed	-$37.2K	–	1202
2025 Q1	$37.2K	Sell	1,791 -14	-0.8%	-$352	﹤0.01%	604
2024 Q4	$42.5K	Hold	1,805	–	–	﹤0.01%	568
2024 Q3	$46.2K	Hold	1,805	–	–	0.01%	557
2024 Q2	$42.4K	Hold	1,805	–	–	0.01%	533
2024 Q1	$51.9K	Sell	1,805 -14	-0.8%	-$421	0.01%	467
2023 Q4	$59.7K	Hold	1,819	–	–	0.01%	408
2023 Q3	$50.7K	Hold	1,819	–	–	0.01%	415
2023 Q2	$62K	Buy	1,819 +165	+10%	+$5.19K	0.01%	395
2023 Q1	$49.7K	Buy	1,654 +325	+24%	+$10.1K	0.01%	425
2022 Q4	$37.5K	Buy	1,329 +1,301	+4,646%	+$41.3K	0.01%	385
2022 Q3	$1K	Hold	28	–	–	﹤0.01%	715
2022 Q2	$1K	Hold	28	–	–	﹤0.01%	779
2022 Q1	$1K	Hold	28	–	–	﹤0.01%	895
2021 Q4	$2K	Sell	28 -190	-87%	-$13.1K	﹤0.01%	811
2021 Q3	$16K	Sell	218 -20	-8%	-$1.68K	﹤0.01%	538
2021 Q2	$22K	Buy	238 +28	+13%	+$2.38K	﹤0.01%	433
2021 Q1	$19K	Hold	210	–	–	﹤0.01%	443
2020 Q4	$20K	Hold	210	–	–	﹤0.01%	429
2020 Q3	$13K	Hold	210	–	–	﹤0.01%	410
2020 Q2	$11K	Hold	210	–	–	﹤0.01%	466
2020 Q1	$7K	Hold	210	–	–	﹤0.01%	478
2019 Q4	$7K	Hold	210	–	–	﹤0.01%	479
2019 Q3	$6K	Hold	210	–	–	﹤0.01%	476
2019 Q2	$7K	Buy	+210	New	+$6.73K	﹤0.01%	504

Other funds holding ARKG

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Manchester Capital Management's ARKG Position: Q2 2026 in Review

Manchester Capital Management held its ARK Genomic Revolution ETF (ARKG) position steady in Q2 2026 at 2,160 shares worth $90.8K. The position accounts for 0.01% of the portfolio, ranked #405.

Manchester Capital Management first reported a position in ARKG in Q2 2019 and has held it in 26 quarters since. 271 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

Manchester Capital Management held 2,160 shares of ARK Genomic Revolution ETF worth $90.8K as of Q2 2026.
Manchester Capital Management left its ARK Genomic Revolution ETF share count unchanged in Q2 2026.
ARK Genomic Revolution ETF made up 0.01% of Manchester Capital Management's portfolio in Q2 2026, its #405 holding.
Manchester Capital Management first reported a position in ARK Genomic Revolution ETF in Q2 2019 and has held it in 26 quarters since.
271 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Manchester Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.